The scrip had closed at Rs 691.7 in the previous session. The stock quoted a 52-week low of Rs 660.1 and a high of Rs 1063.75. The company quoted a market-cap of Rs 40590.9 crore on the BSE.
On BSE, 30,468 shares have changed hands on the counter so far. At its prevailing price, the stock traded at 7.62 times its trailing 12-month EPS of Rs 90.87 per share and 2.36 times its book value. The return on equity (ROE) stood at Rs 24.32.
Key Financials
For the quarter ended 30-Jun-2021, Aurobindo Pharma Ltd. reported consolidated sales of Rs 5783.29 crore, down 4.26 per cent from the same quarter a year ago. The company reported 1.36 per cent YoY de-growth in net profit at Rs 769.97 crore for the latest quarter.
Technical indicators
The relative strength index (RSI) of the stock stood at Wednesday. The RSI oscillates between zero and 100. Traditionally, it is considered overbought condition when the RSI value is above 70 and oversold when it is below 30.
Analysts say the RSI indicator should not be seen in isolation, as it may not be sufficient to take a trading call, just the way a fundamental analyst cannot give a “buy” or “sell” recommendation using a single valuation ratio.
